Literature DB >> 21816766

Bacteriophages as vehicles of the resistome in cystic fibrosis.

Jean Marc Rolain1, Laura Fancello, Christelle Desnues, Didier Raoult.   

Abstract

Environmental microbial communities and human microbiota represent a huge reservoir of mobilizable genes, the 'mobilome', including a pool of genes encoding antimicrobial resistance, the 'resistome'. Whole-genome sequencing of bacterial genomes from cystic fibrosis (CF) patients has demonstrated that bacteriophages contribute significantly to bacterial genome alterations, and metagenomic analysis of respiratory tract DNA viral communities has revealed the presence of genes encoding antimicrobial resistance in bacteriophages of CF patients. CF airways should now be considered as the site of complex microbiota, where bacteriophages are vehicles for the adaptation of bacteria to this specific environment and for the emergence and selection of multidrug-resistant bacteria with chimeric repertoires. As phages are already known to be mobilized during chronic infection of the lungs of patients with CF, it seems particularly important to improve the understanding of the mechanisms of phage induction to prevent the spread of virulence and/or antimicrobial resistance determinants within the CF population as well as in the community. Such a modern point of view may be a seminal reflection for clinical practice in the future since current antimicrobial therapy guidelines in the context of CF may lead to the emergence of genes encoding antimicrobial resistance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21816766     DOI: 10.1093/jac/dkr318

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  26 in total

Review 1.  Applying insights from biofilm biology to drug development - can a new approach be developed?

Authors:  Thomas Bjarnsholt; Oana Ciofu; Søren Molin; Michael Givskov; Niels Høiby
Journal:  Nat Rev Drug Discov       Date:  2013-10       Impact factor: 84.694

2.  Phages rarely encode antibiotic resistance genes: a cautionary tale for virome analyses.

Authors:  François Enault; Arnaud Briet; Léa Bouteille; Simon Roux; Matthew B Sullivan; Marie-Agnès Petit
Journal:  ISME J       Date:  2016-06-21       Impact factor: 10.302

Review 3.  Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.

Authors:  Axel Dalhoff
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

4.  Bacteriophage-Mediated Risk Pathways Underlying the Emergence of Antimicrobial Resistance via Intrageneric and Intergeneric Recombination of Antibiotic Efflux Genes Across Natural populations of Human Pathogenic Bacteria.

Authors:  Ekaterine Gabashvili; Saba Kobakhidze; Tamar Chkhikvishvili; Leila Tabatadze; Rusudan Tsiklauri; Ketevan Dadiani; Mamuka Kotetishvili
Journal:  Microb Ecol       Date:  2021-09-01       Impact factor: 4.552

5.  Transkingdom Interactions Important for the Pathogenesis of Human Viruses.

Authors:  Andrew Nishimoto; Nicholas Wohlgemuth; Jason Rosch; Stacey Schultz-Cherry; Valerie Cortez; Hannah M Rowe
Journal:  J Infect Dis       Date:  2021-06-16       Impact factor: 5.226

Review 6.  Rhizome of life, catastrophes, sequence exchanges, gene creations, and giant viruses: how microbial genomics challenges Darwin.

Authors:  Vicky Merhej; Didier Raoult
Journal:  Front Cell Infect Microbiol       Date:  2012-08-28       Impact factor: 5.293

Review 7.  Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications.

Authors:  Zuzanna Drulis-Kawa; Grazyna Majkowska-Skrobek; Barbara Maciejewska; Anne-Sophie Delattre; Rob Lavigne
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

Review 8.  Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status.

Authors:  Sami Hraiech; Fabienne Brégeon; Jean-Marc Rolain
Journal:  Drug Des Devel Ther       Date:  2015-07-16       Impact factor: 4.162

9.  Comparative genomics of non-pseudomonal bacterial species colonising paediatric cystic fibrosis patients.

Authors:  Kate L Ormerod; Narelle M George; James A Fraser; Claire Wainwright; Philip Hugenholtz
Journal:  PeerJ       Date:  2015-09-15       Impact factor: 2.984

Review 10.  Evolution and impact of bacterial drug resistance in the context of cystic fibrosis disease and nosocomial settings.

Authors:  Dinesh Sriramulu
Journal:  Microbiol Insights       Date:  2013-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.